Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP

Journal of NeuroVirology

Volumn 4, Issue 6, 1998, Pages 586-593

  Nagai, Masahiro ^a   Usuku, Koichiro ^b   Matsumoto, Wataru ^b   Kodama, Daisuke ^b   Takenouchi, Norihiro ^b   Moritoyo, Takashi ^b   Hashiguchi, Seiichi ^c   Ichinose, Mamoru ^c   Bangham, Charles R M ^d   Izumo, Shuji ^a   Osame, Mitsuhiro ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c Kagoshima Red Cross Blood Center   (Japan)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Asymptomatic carrier; HTLV I associated myelopathy tropical spastic paraparesis (HAM TSP); Human T cell lymphotropic virus type I (HTLV I); Proviral load; Quantitative PCR

Indexed keywords

DNA; NEOPTERIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; DNA PROBE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; STATISTICAL ANALYSIS; VIRUS CARRIER; VIRUS REPLICATION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0032435810     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809114225     Document Type: Article

References (42)

1. Ali A, Rudge P, Dalgleish AG (1992). Neopterin concentration in serum and cerebrospinal fluid in HTLV-I infected individuals. J Neurol 239: 270-272.
2. Dhawan S, Weeks BS, Abbasi F et al (1993). Increased expression of alpha 4 beta 1 and alpha 5 beta 1 integrins on HTLV-I-infected lymphocytes. Virology 197: 778-781.
3. Eiraku N, Ijichi S, Yashiki S et al (1992). Cell surface phenotype of in vitro proliferating lymphocytes in HTLV-I-associated myelopathy (HAM/TSP). J Neuroimmunol 37: 223-228.
4. Furukawa Y, Fujisawa J, Osame M et al (1992). Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-1-associated myelopathy (HAM-TSP). Blood 80: 1012-1016.
5. Gessain A, Barin F, Vernant JC et al (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407-410.
6. Gessain A, Saal F, Gout O et al (1990). High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood 75: 428-433.
7. Harrington WJ, Jr., Sheremata WA, Snodgrass SR et al (1991). Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol. AIDS Res Hum Retrovirus 7: 1031-1034.
8. Hashimoto K, Higuchi I, Osame M et al (1998). Quantitative in situ PCR assay of HTLV-I infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers. J Neurol Sci, 159: 67-72.
9. Heid CA, Stevens J, Livak KJ, Williams PM (1996). Real time quantitative PCR. Genome Res 6: 986-994.
10. Hollsberg P, Hafler DA (1995). What is the pathogenesis of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis?. Ann Neurol 37: 143-145.
11. Ichinose K, Nakamura T, Kawakami A et al (1992). Increased adherence of T cells to human endothelial cells in patients with human T-cell lymphotropic virus type I-associated myelopathy. Arch Neurol 49: 74-76.
12. Ichinose K, Nakamura T, Nishiura Y et al (1994). Characterization of adherent T cells to human endothelial cells in patients with HTLV-I-associated myelopathy. J Neurol Sci 122: 204-209.
13. Ijichi S, Izumo S, Eiraku N et al (1993). An auto-aggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses 41: 542-547.
14. Itoyama Y, Minato S, Kira J et al (1988). Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology 38: 1302-1307.
15. Izumo S, Ijichi T, Higuchi I et al (1992). Neuropathology of HTLV-I-associated myelopathy - a report of two autopsy cases. Acta Paediatr Jpn 34: 358-364.
16. Jacobson S, Zaninovic V, Mora C et al (1988). Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis. Ann Neurol 23 (Suppl): S196-S200.
17. Jacobson S, Shida H, McFarlin DE et al (1990). Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245-248.
18. Jacobson S (1996). Cellular immune responses to HTLV-I: immunopathogenic role in HTLV-I-associated neurologic disease. J Acquir Immune Defic Syndr Hum Retrovirol 13: S100-S106.
19. Kaplan JE, Osame M, Kubota H et al (1990). The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 3: 1096-1101.
20. Khabbaz RF, Onorato IM, Cannon RO et al (1992). Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 326: 375-380.
21. Kira J, Koyanagi Y, Yamada T et al (1991). Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 29: 194-201.
22. Kubota R, Fujiyoshi T, Izumo S et al (1993). Fluctuation of HTLV-I provirol DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol 42: 147-154.
23. Machigashira K, Ijichi S, Nagai M et al (1997). In vitro virus propagation and high cellular responsiveness to the infected cells in patients with HTLV-I-associated myelopathy (HAM/TSP). J Neurol Sci 149: 141-145.
24. Matsuoka E, Takenouchi N, Hashimoto K et al (1998). Perivascular T-cells are infected with HTLV-I in the spinal cord lesions with HAM/TSP: Double staining of immunohistochemistry and PCR in situ hybridization. Acta Neuropathy Berl, 96: 340-346.
25. Mellors JW, Munoz A, Giorgi JV et al (1997). Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 126: 946-954.
26. Melo A, Moura L, Meireles A, Costa G Danazol (1992). A new perspective in the treatment of HTLV-1 associated myelopathy (preliminary report). Arq-Neuropsiquiatr 50: 402-403.
27. Moritoyo T, Reinhart TA, Moritoyo H et al (1996). Human T-lumphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 40: 84-90.
28. Nagai M, Yashiki S, Fujiyoshi T et al (1996). Characterization of a unique T-cell clone established from a patient with HAM/TSP which recognized HTLV-I-infected T-cell antigens as well as spinal cord tissue antigens. J Neuroimmunol 65: 97-105.
29. Nomoto M, Utatsu Y, Soejima Y, Osame M (1991). Neopterin in cerebrospinal fluid: a useful marker for diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis. Neurology 41: 457.
30. O'Brien WA, Hartigan PM, Martin D et al (1996). Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 334: 426-431.
31. Osame M, Usuku K, Izumo S et al (1986). HTLV-I associated myelopathy, a new clinical entity [letter]. Lancet 1: 1031-1032.
32. Osame M, Matsumoto M, Usuku K et al (1987). Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol 21: 117-122.
33. Osame M (1990a). Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Human Retrovirology: HTLV, W.A. Blattner (ed.), Raven Press: New York, pp 191-197.
34. Osame M, Janssen R, Kubota H et al (1990b). Nationwide survey of HTLV-I-associated myelopathy in Japan: Association with blood transfusion. Ann Neurol 28: 50-56.
35. Parker CE, Daenke S, Nightingale S, Bangham CR (1992). Activated HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 188: 628-636.
36. Saag MS, Holodniy M, Kuritzkes DR et al (1996). HIV viral load markers in clinical practice. Nat Med 2: 625-629.
37. Sonoda S, Yashiki S, Takahashi K et al (1987). Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia/lymphoma patients and their relatives, Int J Cancer 40: 629-634.
38. Tateno M (1987). Rat lymphoid cell lines producing human T cell leukemia virus-I. Hokkaido Igaku Zasshi 62: 74-81.
39. Umehara F, Izumo S, Nakagawa M et al (1993). Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 52: 424-430.
40. Umehara F, Izumo S, Ronquillo AT et al (1994). Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 53: 72-77.
41. Usuku K, Sonoda S, Osame M et al (1988). HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol 23 (Suppl): S143-S150.
42. Yoshida M, Osame M, Kawai H et al (1989). Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol 26: 331-335.